Literature DB >> 12878549

Antimicrobial susceptibilities of group B streptococci in New Zealand.

Anja M Werno, Trevor P Anderson, David R Murdoch.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12878549      PMCID： PMC166078          DOI： 10.1128/AAC.47.8.2710-2711.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  15 in total

1.  Change in antibiotic resistance of group B streptococcus: impact on intrapartum management.

Authors:  W J Morales; S S Dickey; P Bornick; D V Lim
Journal:  Am J Obstet Gynecol       Date:  1999-08       Impact factor: 8.661

2.  Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators.

Authors:  G J Tyrrell; L D Senzilet; J S Spika; D A Kertesz; M Alagaratnam; M Lovgren; J A Talbot
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

3.  Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.

Authors:  D De Mouy; J D Cavallo; R Leclercq; R Fabre
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

4.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

5.  Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures.

Authors:  M L Bland; S T Vermillion; D E Soper; M Austin
Journal:  Am J Obstet Gynecol       Date:  2001-05       Impact factor: 8.661

Review 6.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

7.  Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Authors:  D R Murdoch; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors:  J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Is penicillin and/or erythromycin resistance present in clinical isolates of group B streptococcus in our community?

Authors:  Anastasia Stylianopoulos; Nigel Kelly; Suzanne Garland
Journal:  Aust N Z J Obstet Gynaecol       Date:  2002-11       Impact factor: 2.100

10.  Late antenatal carriage of group B Streptococcus by New Zealand women.

Authors:  Keith Grimwood; Peter R Stone; Isobelle A Gosling; Robyn Green; Brian A Darlow; Diana R Lennon; Diana R Martin
Journal:  Aust N Z J Obstet Gynaecol       Date:  2002-05       Impact factor: 2.100
View more
  2 in total

1.  Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay.

Authors:  Xianyu Zeng; Fanrong Kong; Hui Wang; Archie Darbar; Gwendolyn L Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Cross-resistance to lincosamides, streptogramins A, and pleuromutilins due to the lsa(C) gene in Streptococcus agalactiae UCN70.

Authors:  Brigitte Malbruny; Anja M Werno; David R Murdoch; Roland Leclercq; Vincent Cattoir
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.